Maximizing the success of analgesic clinical trials with 

tailored QST Solutions 

Why QST?

  • Phenotyping patients based on underlying pain mechanisms

  • Secondary outcome measures

  • Safety outcome measures

“… the European Medicines Agency (EMA) has recently acknowledged […] that sensory profiling and subgrouping […] is an adequate stratification tool for determining specific sensory phenotypes of patients…”     (EMA 2016, Baron et al., 2017)

Early design phase support including research and guidelines

Recommendations for advanced QST test batteries and QST endpoints

Streamlined, plug & play technologies with easy setup and operation

Customized software and reports for a program/trial-specific protocol and needs

Multi-layer training approach, including IM materials, trainings at sites, webinars and more

Ongoing, comprehensive support covering all elements of QST performance, monitoring and protocol execution

Medoc Ltd.

© 1990-2020 by Medoc

  • Facebook - White Circle
  • LinkedIn - White Circle
  • YouTube
  • Twitter

1 Hadekel St., Ramat Yishay, 30095 Israel